Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen‐B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

OBJECTIVE: Axial disease is common and burdensome in patients with psoriatic arthritis (PsA). Human leukocyte antigen‐B27 (HLA‐B27) is a risk factor for axial PsA; treatment response by HLA‐B27 status is inadequately characterized. This study evaluated responses to biologic disease‐modifying antirhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip J., Chakravarty, Soumya D., McLean, Robert R., Blachley, Taylor, Kawashima, Toana, Lin, Iris, Kavanaugh, Arthur, Ogdie, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096522/
https://www.ncbi.nlm.nih.gov/pubmed/35218320
http://dx.doi.org/10.1002/acr2.11416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096522/
https://www.ncbi.nlm.nih.gov/pubmed/35218320
http://dx.doi.org/10.1002/acr2.11416

Ejemplares similares